ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
59,102.04
1.48%
S&P 500
5,041.23
0.46%
Dow Jones
38,080.36
0.47%
US Dollar vs Yen
153.7785
-1.24%
Brent Oil
83.225
-0.38%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Cassava Sciences Inc (SAVA)

  7. Cassava Sciences Inc (SAVA) ニュース

SAVA Cassava Sciences Inc

22.02
-0.12 (-0.54%)
最終更新日： 00:50:03
15分遅延
名称 銘柄コード 市場 種別
Cassava Sciences Inc SAVA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
-0.12 -0.54% 22.02 00:50:03
始値 安値 高値 終値 前日終値
22.20 21.95 22.25 22.14
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0122:10GLOBETomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
2024/4/1522:20GLOBERedemption Date Announced for Warrants
2024/3/2522:13GLOBECassava Sciences Announces Completion of an Interim Safety..
2024/3/0423:15GLOBECassava Sciences Announces Virtual Presentation at the..
2024/2/2906:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2823:22EDGAR2Form 8-K - Current report
2024/2/2823:14GLOBECassava Sciences Reports Full-year 2023 Financial Results..
2024/2/0723:20EDGAR2Form 8-K - Current report
2024/2/0723:08GLOBENo Decline in Cognition Scores in Patients with Mild..
2024/2/0206:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2706:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0523:12GLOBECassava Sciences Completes Dividend Distribution of Warrants..
2024/1/0406:24EDGAR2Form CERT - Certification by an exchange approving..
2024/1/0406:22EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
2024/1/0406:18EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
2024/1/0323:10EDGAR2Form 8-K - Current report
2024/1/0223:10EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
2023/12/1223:19EDGAR2Form 8-K - Current report
2023/12/1223:13GLOBECassava Sciences Announces Dividend Distribution of Warrants..
2023/12/1206:18EDGAR2Form 8-K - Current report
2023/12/0907:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0806:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0806:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0806:01GLOBECassava Sciences Appoints Three New Members to its Board of..
2023/11/0723:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0723:08EDGAR2Form 8-K - Current report
2023/11/0723:01GLOBECassava Sciences Reports Third Quarter 2023 Financial and..
2023/11/0623:15GLOBECassava Sciences Completes Enrollment for Pivotal Phase 3..
2023/10/2522:15GLOBEMRI Data Suggest Simufilam is Not Associated with..
2023/10/1322:06IHMARKETNEWSFriday’s Wall Street Highlights: Dollar General, Microsoft,..
2023/10/1312:43GLOBEStatement by Cassava Sciences Regarding an Internal CUNY..
2023/10/0522:15GLOBECassava Sciences to Present at the Jefferies Biotech..
2023/10/0507:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0507:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0507:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0507:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0222:00GLOBECassava Sciences Completes Patient Enrollment for Pivotal..
2023/9/1822:15GLOBECassava Sciences Announces Positive Interim Safety Review of..
2023/9/1405:17EDGAR2Form 8-K - Current report
2023/9/1122:10GLOBECassava Sciences Announces Science Publication That Confirms..
2023/9/0622:15GLOBECassava Sciences Invited to Present in Four Upcoming..
2023/8/2505:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2405:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0405:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0322:12EDGAR2Form 8-K - Current report
2023/8/0322:07GLOBECassava Sciences Reports Q2 2023 Financial Results and..
2023/7/0522:25EDGAR2Form 8-K - Current report
2023/7/0522:15GLOBEOral Simufilam Slowed Cognitive Decline in a Randomized..
2023/6/2722:15GLOBENew Research Shows Simufilam Suppresses Overactive mTOR
2023/6/1222:15GLOBENew Publication Highlights Basic Science Supporting..

最近閲覧した銘柄

NASDAQ
SAVA
Cassava Sciences
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有